$13.99
0.030.21%
Pre-Market: 7:04 AM EDT
Comments
Loading...
Adient Analyst Ratings and Price Targets | NYSE:ADNT | Benzinga
Adient PLC has a consensus price target of $29.21 based on the ratings of 16 analysts. The high is $62 issued by Benchmark on August 7, 2023. The low is $17 issued by Morgan Stanley on March 3, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Morgan Stanley, and UBS on March 4, 2025, March 3, 2025, and January 29, 2025, respectively. With an average price target of $18.33 between B of A Securities, Morgan Stanley, and UBS, there's an implied 31.05% upside for Adient PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Morgan Stanley
UBS
JP Morgan
Barclays
1calculated from analyst ratings
Analyst Ratings for Adient
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | Buy Now | 28.66% | B of A Securities | John Murphy53% | $24 → $18 | Downgrade | Neutral → Underperform | Get Alert |
| 03/03/2025 | Buy Now | 21.52% | Morgan Stanley | Adam Jonas62% | $19 → $17 | Maintains | Underweight | Get Alert |
| 01/29/2025 | Buy Now | 42.96% | UBS | Joseph Spak43% | $19 → $20 | Maintains | Neutral | Get Alert |
| 01/27/2025 | Buy Now | 50.11% | JP Morgan | Ryan Brinkman52% | $24 → $21 | Maintains | Neutral | Get Alert |
| 01/22/2025 | Buy Now | 50.11% | Barclays | Dan Levy42% | $24 → $21 | Maintains | Equal-Weight | Get Alert |
| 12/16/2024 | Buy Now | 42.96% | Wells Fargo | Colin Langan49% | $27 → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/21/2024 | Buy Now | 71.55% | B of A Securities | John Murphy53% | $30 → $24 | Downgrade | Buy → Neutral | Get Alert |
| 11/14/2024 | Buy Now | 35.81% | Morgan Stanley | Adam Jonas62% | $21 → $19 | Maintains | Underweight | Get Alert |
| 10/14/2024 | Buy Now | 114.44% | B of A Securities | John Murphy53% | $35 → $30 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | 92.99% | Wells Fargo | Colin Langan49% | $38 → $27 | Maintains | Overweight | Get Alert |
| 09/10/2024 | Buy Now | 71.55% | Deutsche Bank | Edison Yu27% | → $24 | Reinstates | → Hold | Get Alert |
| 09/05/2024 | Buy Now | — | Wolfe Research | Emmanuel Rosner73% | — | Initiates | → Peer Perform | Get Alert |
| 08/14/2024 | Buy Now | 50.11% | Morgan Stanley | Adam Jonas62% | $32 → $21 | Maintains | Underweight | Get Alert |
| 08/08/2024 | Buy Now | 92.99% | JP Morgan | Ryan Brinkman52% | $31 → $27 | Maintains | Neutral | Get Alert |
| 08/08/2024 | Buy Now | 71.55% | Barclays | Dan Levy42% | $29 → $24 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | Buy Now | 71.55% | UBS | Joseph Spak43% | $27 → $24 | Maintains | Neutral | Get Alert |
| 07/22/2024 | Buy Now | 185.92% | B of A Securities | John Murphy53% | $42 → $40 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 121.59% | JP Morgan | Ryan Brinkman52% | $32 → $31 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 107.29% | Barclays | Dan Levy42% | $34 → $29 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 92.99% | UBS | Colin Langan49% | $31 → $27 | Maintains | Neutral | Get Alert |
| 07/01/2024 | Buy Now | 85.85% | Exane BNP Paribas | James Picariello73% | → $26 | Upgrade | Underperform → Neutral | Get Alert |
| 06/25/2024 | Buy Now | 128.73% | Wells Fargo | Colin Langan49% | $33 → $32 | Maintains | Overweight | Get Alert |
| 05/10/2024 | Buy Now | 128.73% | Morgan Stanley | Adam Jonas62% | $35 → $32 | Maintains | Underweight | Get Alert |
| 05/07/2024 | Buy Now | 128.73% | JP Morgan | Ryan Brinkman52% | $37 → $32 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | 143.03% | Barclays | Dan Levy42% | $37 → $34 | Maintains | Equal-Weight | Get Alert |
| 05/06/2024 | Buy Now | 121.59% | UBS | Joseph Spak43% | $36 → $31 | Maintains | Neutral | Get Alert |
| 05/06/2024 | Buy Now | 114.44% | Deutsche Bank | Emmanuel Rosner73% | $32 → $30 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 135.88% | Wells Fargo | Colin Langan49% | $38 → $33 | Maintains | Overweight | Get Alert |
| 04/22/2024 | Buy Now | 164.47% | JP Morgan | Ryan Brinkman52% | $40 → $37 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | 164.47% | Barclays | Dan Levy42% | $41 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | 228.81% | B of A Securities | John Murphy53% | $50 → $46 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | 171.62% | Wells Fargo | Colin Langan49% | $40 → $38 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 185.92% | JP Morgan | Ryan Brinkman52% | $41 → $40 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 193.07% | Barclays | Dan Levy42% | $43 → $41 | Maintains | Overweight | Get Alert |
| 02/08/2024 | Buy Now | 185.92% | Wells Fargo | Colin Langan49% | $41 → $40 | Maintains | Overweight | Get Alert |
| 01/24/2024 | Buy Now | 207.36% | Barclays | Dan Levy42% | $47 → $43 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | 150.18% | Morgan Stanley | Adam Jonas62% | $38 → $35 | Maintains | Underweight | Get Alert |
| 11/10/2023 | Buy Now | 235.95% | Barclays | Dan Levy42% | $52 → $47 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 157.33% | UBS | Joseph Spak43% | $40 → $36 | Maintains | Neutral | Get Alert |
| 11/09/2023 | Buy Now | 193.07% | Wells Fargo | Colin Langan49% | $49 → $41 | Maintains | Overweight | Get Alert |
| 10/13/2023 | Buy Now | 271.69% | Barclays | Dan Levy42% | $54 → $52 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | 185.92% | UBS | Colin Langan49% | $43 → $40 | Maintains | Neutral | Get Alert |
| 09/13/2023 | Buy Now | 207.36% | UBS | Colin Langan49% | → $43 | Initiates | → Neutral | Get Alert |
| 08/08/2023 | Buy Now | 171.62% | Morgan Stanley | Adam Jonas62% | $35 → $38 | Maintains | Underweight | Get Alert |
| 08/07/2023 | Buy Now | 343.17% | Benchmark | Michael Ward76% | $58 → $62 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 285.99% | Barclays | Dan Levy42% | $50 → $55 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 200.21% | JP Morgan | Ryan Brinkman52% | $38 → $42 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | 221.66% | Wells Fargo | Colin Langan49% | $48 → $45 | Maintains | Overweight | Get Alert |
| 06/01/2023 | Buy Now | — | Exane BNP Paribas | James Picariello73% | — | Downgrade | Neutral → Underperform | Get Alert |
| 05/04/2023 | Buy Now | 243.1% | Wells Fargo | Colin Langan49% | $49 → $48 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 257.4% | Barclays | Dan Levy42% | $54 → $50 | Maintains | Overweight | Get Alert |
| 04/17/2023 | Buy Now | 285.99% | Barclays | Dan Levy42% | $57 → $54 | Maintains | Overweight | Get Alert |
| 04/10/2023 | Buy Now | 250.25% | Wells Fargo | Colin Langan49% | $50 → $49 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | 307.43% | Barclays | Dan Levy42% | → $57 | Initiates | → Overweight | Get Alert |
| 02/09/2023 | Buy Now | 150.18% | Morgan Stanley | Adam Jonas62% | $29 → $35 | Maintains | Underweight | Get Alert |
| 02/09/2023 | Buy Now | — | Wolfe Research | Rod Lache49% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 02/08/2023 | Buy Now | 257.4% | Wells Fargo | Colin Langan49% | $46 → $50 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 328.88% | Benchmark | Michael Ward76% | $48 → $60 | Maintains | Buy | Get Alert |
| 01/25/2023 | Buy Now | 171.62% | JP Morgan | Ryan Brinkman52% | $35 → $38 | Maintains | Neutral | Get Alert |
| 01/17/2023 | Buy Now | 228.81% | Wells Fargo | Colin Langan49% | $41 → $46 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | 271.69% | B of A Securities | John Murphy53% | $41 → $52 | Upgrade | Neutral → Buy | Get Alert |
| 11/28/2022 | Buy Now | 107.29% | Morgan Stanley | Adam Jonas62% | $27 → $29 | Maintains | Underweight | Get Alert |
| 11/08/2022 | Buy Now | 178.77% | Deutsche Bank | Emmanuel Rosner73% | → $39 | Downgrade | Buy → Hold | Get Alert |
| 11/07/2022 | Buy Now | 200.21% | Wells Fargo | Colin Langan49% | $37 → $42 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 157.33% | RBC Capital | Joseph Spak43% | → $36 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/09/2022 | Buy Now | 193.07% | B of A Securities | John Murphy53% | $48 → $41 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | 221.66% | Wells Fargo | Colin Langan49% | $41 → $45 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 92.99% | Morgan Stanley | Adam Jonas62% | $31 → $27 | Maintains | Underweight | Get Alert |
| 07/11/2022 | Buy Now | 193.07% | Wells Fargo | Colin Langan49% | $43 → $41 | Maintains | Overweight | Get Alert |
| 06/02/2022 | Buy Now | 121.59% | Morgan Stanley | Adam Jonas62% | $36 → $31 | Maintains | Underweight | Get Alert |
| 05/19/2022 | Buy Now | 257.4% | Credit Suisse | Dan Levy42% | $55 → $50 | Maintains | Outperform | Get Alert |
| 04/21/2022 | Buy Now | 193.07% | Deutsche Bank | Emmanuel Rosner73% | $59 → $41 | Maintains | Buy | Get Alert |
| 04/07/2022 | Buy Now | 164.47% | Barclays | Brian Johnson51% | $45 → $37 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | Buy Now | 157.33% | Morgan Stanley | Adam Jonas62% | $38 → $36 | Maintains | Underweight | Get Alert |
| 04/01/2022 | Buy Now | 257.4% | Wells Fargo | Colin Langan49% | $60 → $50 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Adient (ADNT) stock?
The latest price target for Adient (NYSE:ADNT) was reported by B of A Securities on March 4, 2025. The analyst firm set a price target for $18.00 expecting ADNT to rise to within 12 months (a possible 28.66% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Adient (ADNT)?
The latest analyst rating for Adient (NYSE:ADNT) was provided by B of A Securities, and Adient downgraded their underperform rating.
When was the last upgrade for Adient (ADNT)?
The last upgrade for Adient PLC happened on July 1, 2024 when Exane BNP Paribas raised their price target to $26. Exane BNP Paribas previously had an underperform for Adient PLC.
When was the last downgrade for Adient (ADNT)?
The last downgrade for Adient PLC happened on March 4, 2025 when B of A Securities changed their price target from $24 to $18 for Adient PLC.
When is the next analyst rating going to be posted or updated for Adient (ADNT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adient was filed on March 4, 2025 so you should expect the next rating to be made available sometime around March 4, 2026.
Is the Analyst Rating Adient (ADNT) correct?
While ratings are subjective and will change, the latest Adient (ADNT) rating was a downgraded with a price target of $24.00 to $18.00. The current price Adient (ADNT) is trading at is $13.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.